The global vaccine alliance Gavi says it will buy 500,000 doses of vaccine against mpox to fight outbreaks of the disease in African countries.

Gavi, the global vaccine group, announced it will purchase 500,000 doses of Bavarian Nordic’s mpox vaccine. This marks Gavi’s first acquisition of the vaccine to aid in combating an outbreak in parts of Africa.

Gavi, the Vaccine Alliance, and Bavarian Nordic today announced an advanced purchase agreement to secure 500,000 doses of Jynneos mpox vaccine for African countries, which will be delivered this year.